Eric Lefkofsky is well known as the co-founder of Groupon, but many aren’t aware that he has a hand in the advancement of medical technology. Although his background in data wouldn’t initially be viewed as medical in nature, he definitely has applied a great deal of time and effort to the cause in respect to cancer research. Eric’s wife was diagnosed with breast cancer and it left him devastated as a husband. Not one to leave it up to conventional medicine and treatment, he sought to completely revamp the process in which data and information is collected.
The result of the aforementioned events led to the formation of Tempus, a company that specializes in precision based medicine. When molecular data is part of the conversation, Eric Lefkofsky knows how important artificial intelligence and data mining is when it comes to streamlining many processes. Another great benefit from this endeavor is the fact that Tempus has not only revolutionized data collection in regard to cancer treatment, but other disease research as well.
Eric established the Lefkofsky Family Foundation in 2006 with his wife Liz, and the goal of the foundation is to enhance the live of the many affected by the disease. They are also members of the Giving Pledge with a promise to donate more than half of their wealth to the cause. All in all Eric Lefkofsky and Tempus will transform the way cancer care is applied and delivered, while also giving back to communities and those affected by the experience of dealing with the disease as well.
Many will benefit from the research and time that has been put in to change not only the medical data aspect of cancer research, but also how many view cancer as well. Sadly too many people see it as a death sentence and many factors are to blame. Mr. Lefkofsky actively seeks to lessen the stress of such a rampant disease by streamlining the medical records as well as researching gene and molecular data.